Article

FDA approves first test of CRISPR to correct genetic defect causing sickle cell disease | Berkeley News

Berkeley News (2021)

UC scientists and physicians hope to permanently cure patients of sickle cell disease by using CRISPR-Cas9 to replace a defective gene with the normal version

View Original Source


View All Articles

Comments

No comments yet. Be the first to comment!

Chunks with this Article

1 chunk • used in 1 course
CRISPR, gene editing and DNA manipulation - examples, use cases
a collection of articles with examples and use cases of CRISPR, gene editing and DNA manipulation
CourseChunks
13 resources

RELATED RESOURCES

with chunks in common

MORE RELATED CONTENT

with shared categories

MORE RESOURCES FROM SOURCE

More in Course Chunks from   Berkeley News